https:\/\/telixpharma.com\/news-views\/zircon-phase-iii-top-line-data-study-meets-primary-objectives\/<\/a>
\n
\n\u00a0<\/p>\n\n<\/p>\n","protected":false},"excerpt":{"rendered":"
Gefeliciteerd Telix met de positieve resultaten van jullie fase III studie. We zijn blij dat we aan deze studie hebben kunnen meewerken. Voor het volledige bericht van Telix: https:\/\/telixpharma.com\/news-views\/zircon-phase-iii-top-line-data-study-meets-primary-objectives\/
\u00a0<\/p>\n","protected":false},"author":8,"featured_media":3171,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[26,25,32],"class_list":["post-3172","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-zonder-categorie","tag-amsterdam-umc-nl","tag-cyclotron-nl","tag-pet-tracer-nl"],"yoast_head":"\n
Klinische fase III studie met GMP-compliant Zr-89 van BV Cyclotron VU, Amsterdam succesvol afgerond - Cyclotron<\/title>\n<meta name=\"description\" content=\"Gefeliciteerd Telix met de positieve resultaten van jullie fase III studie. We zijn blij dat we aan deze studie hebben kunnen meewerken.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Klinische fase III studie met GMP-compliant Zr-89 van BV Cyclotron VU, Amsterdam succesvol afgerond - Cyclotron\" \/>\n<meta property=\"og:description\" content=\"Gefeliciteerd Telix met de positieve resultaten van jullie fase III studie. We zijn blij dat we aan deze studie hebben kunnen meewerken.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/\" \/>\n<meta property=\"og:site_name\" content=\"Cyclotron\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-08T09:58:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-08T09:58:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2022\/11\/Kidney_Cancer-crop-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"3001\" \/>\n\t<meta property=\"og:image:height\" content=\"3138\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Marike van der Zee\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marike van der Zee\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/\"},\"author\":{\"name\":\"Marike van der Zee\",\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/#\/schema\/person\/b3d69a26f7d05a0f5e6993e9ef7a653e\"},\"headline\":\"Klinische fase III studie met GMP-compliant Zr-89 van BV Cyclotron VU, Amsterdam succesvol afgerond\",\"datePublished\":\"2022-11-08T09:58:57+00:00\",\"dateModified\":\"2022-11-08T09:58:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/\"},\"wordCount\":47,\"publisher\":{\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2022\/11\/Kidney_Cancer-crop-1.png\",\"keywords\":[\"Amsterdam UMC\",\"Cyclotron\",\"PET tracer\"],\"articleSection\":[\"Zonder categorie\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/\",\"url\":\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/\",\"name\":\"Klinische fase III studie met GMP-compliant Zr-89 van BV Cyclotron VU, Amsterdam succesvol afgerond - Cyclotron\",\"isPartOf\":{\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2022\/11\/Kidney_Cancer-crop-1.png\",\"datePublished\":\"2022-11-08T09:58:57+00:00\",\"dateModified\":\"2022-11-08T09:58:58+00:00\",\"description\":\"Gefeliciteerd Telix met de positieve resultaten van jullie fase III studie. We zijn blij dat we aan deze studie hebben kunnen meewerken.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#primaryimage\",\"url\":\"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2022\/11\/Kidney_Cancer-crop-1.png\",\"contentUrl\":\"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2022\/11\/Kidney_Cancer-crop-1.png\",\"width\":3001,\"height\":3138},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cyclotron.nl\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Klinische fase III studie met GMP-compliant Zr-89 van BV Cyclotron VU, Amsterdam succesvol afgerond\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/#website\",\"url\":\"https:\/\/www.cyclotron.nl\/nl\/\",\"name\":\"Cyclotron\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cyclotron.nl\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/#organization\",\"name\":\"BV Cyclotron VU\",\"url\":\"https:\/\/www.cyclotron.nl\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2019\/09\/cyclo_logo_rgb_rz_save_for_web-1-e1572867104182.jpg\",\"contentUrl\":\"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2019\/09\/cyclo_logo_rgb_rz_save_for_web-1-e1572867104182.jpg\",\"width\":2048,\"height\":535,\"caption\":\"BV Cyclotron VU\"},\"image\":{\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"http:\/\/linkedin.com\/company\/bv-cyclotron-vu\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cyclotron.nl\/nl\/#\/schema\/person\/b3d69a26f7d05a0f5e6993e9ef7a653e\",\"name\":\"Marike van der Zee\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Klinische fase III studie met GMP-compliant Zr-89 van BV Cyclotron VU, Amsterdam succesvol afgerond - Cyclotron","description":"Gefeliciteerd Telix met de positieve resultaten van jullie fase III studie. We zijn blij dat we aan deze studie hebben kunnen meewerken.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/","og_locale":"nl_NL","og_type":"article","og_title":"Klinische fase III studie met GMP-compliant Zr-89 van BV Cyclotron VU, Amsterdam succesvol afgerond - Cyclotron","og_description":"Gefeliciteerd Telix met de positieve resultaten van jullie fase III studie. We zijn blij dat we aan deze studie hebben kunnen meewerken.","og_url":"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/","og_site_name":"Cyclotron","article_published_time":"2022-11-08T09:58:57+00:00","article_modified_time":"2022-11-08T09:58:58+00:00","og_image":[{"width":3001,"height":3138,"url":"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2022\/11\/Kidney_Cancer-crop-1.png","type":"image\/png"}],"author":"Marike van der Zee","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"Marike van der Zee"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#article","isPartOf":{"@id":"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/"},"author":{"name":"Marike van der Zee","@id":"https:\/\/www.cyclotron.nl\/nl\/#\/schema\/person\/b3d69a26f7d05a0f5e6993e9ef7a653e"},"headline":"Klinische fase III studie met GMP-compliant Zr-89 van BV Cyclotron VU, Amsterdam succesvol afgerond","datePublished":"2022-11-08T09:58:57+00:00","dateModified":"2022-11-08T09:58:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/"},"wordCount":47,"publisher":{"@id":"https:\/\/www.cyclotron.nl\/nl\/#organization"},"image":{"@id":"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2022\/11\/Kidney_Cancer-crop-1.png","keywords":["Amsterdam UMC","Cyclotron","PET tracer"],"articleSection":["Zonder categorie"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/","url":"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/","name":"Klinische fase III studie met GMP-compliant Zr-89 van BV Cyclotron VU, Amsterdam succesvol afgerond - Cyclotron","isPartOf":{"@id":"https:\/\/www.cyclotron.nl\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#primaryimage"},"image":{"@id":"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2022\/11\/Kidney_Cancer-crop-1.png","datePublished":"2022-11-08T09:58:57+00:00","dateModified":"2022-11-08T09:58:58+00:00","description":"Gefeliciteerd Telix met de positieve resultaten van jullie fase III studie. We zijn blij dat we aan deze studie hebben kunnen meewerken.","breadcrumb":{"@id":"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#primaryimage","url":"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2022\/11\/Kidney_Cancer-crop-1.png","contentUrl":"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2022\/11\/Kidney_Cancer-crop-1.png","width":3001,"height":3138},{"@type":"BreadcrumbList","@id":"https:\/\/www.cyclotron.nl\/nl\/klinische-fase-iii-studie-met-gmp-compliant-zr-89-van-bv-cyclotron-vu-amsterdam-succesvol-afgerond\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cyclotron.nl\/nl\/"},{"@type":"ListItem","position":2,"name":"Klinische fase III studie met GMP-compliant Zr-89 van BV Cyclotron VU, Amsterdam succesvol afgerond"}]},{"@type":"WebSite","@id":"https:\/\/www.cyclotron.nl\/nl\/#website","url":"https:\/\/www.cyclotron.nl\/nl\/","name":"Cyclotron","description":"","publisher":{"@id":"https:\/\/www.cyclotron.nl\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cyclotron.nl\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.cyclotron.nl\/nl\/#organization","name":"BV Cyclotron VU","url":"https:\/\/www.cyclotron.nl\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.cyclotron.nl\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2019\/09\/cyclo_logo_rgb_rz_save_for_web-1-e1572867104182.jpg","contentUrl":"https:\/\/www.cyclotron.nl\/wp-content\/uploads\/2019\/09\/cyclo_logo_rgb_rz_save_for_web-1-e1572867104182.jpg","width":2048,"height":535,"caption":"BV Cyclotron VU"},"image":{"@id":"https:\/\/www.cyclotron.nl\/nl\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/linkedin.com\/company\/bv-cyclotron-vu"]},{"@type":"Person","@id":"https:\/\/www.cyclotron.nl\/nl\/#\/schema\/person\/b3d69a26f7d05a0f5e6993e9ef7a653e","name":"Marike van der Zee"}]}},"_links":{"self":[{"href":"https:\/\/www.cyclotron.nl\/nl\/wp-json\/wp\/v2\/posts\/3172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cyclotron.nl\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cyclotron.nl\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cyclotron.nl\/nl\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cyclotron.nl\/nl\/wp-json\/wp\/v2\/comments?post=3172"}],"version-history":[{"count":1,"href":"https:\/\/www.cyclotron.nl\/nl\/wp-json\/wp\/v2\/posts\/3172\/revisions"}],"predecessor-version":[{"id":3173,"href":"https:\/\/www.cyclotron.nl\/nl\/wp-json\/wp\/v2\/posts\/3172\/revisions\/3173"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cyclotron.nl\/nl\/wp-json\/wp\/v2\/media\/3171"}],"wp:attachment":[{"href":"https:\/\/www.cyclotron.nl\/nl\/wp-json\/wp\/v2\/media?parent=3172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cyclotron.nl\/nl\/wp-json\/wp\/v2\/categories?post=3172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cyclotron.nl\/nl\/wp-json\/wp\/v2\/tags?post=3172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}